American-brazilian Aesthetic Meeting
Salt Lake City, Utah
B+Health Score
70B+
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Good
💰
$453K
Total Revenue
📊
$306K
Total Expenses
🏦
$449K
Net Assets
📋
N/A
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Revenue Growth
+46.6%
Year-over-year change (2022 → 2023)
Net Margin
+32.3%
Revenue minus expenses as % of revenue
Filing History
11 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $452,706↑47% | $306,357↑26% | $448,510↑48% | |
| 2022 | $308,705↑23% | $243,165↑44% | $302,161↑28% | — |
| 2021 | $250,636↑46% | $168,485↓24% | $236,621↑53% | — |
| 2020 | $172,012↓49% | $220,292↑4% | $154,470↓24% | — |
| 2019 | $334,912↑308% | $212,087↑204% | $202,750↑154% | — |
| 2018 | $82,035↓64% | $69,847↓62% | $79,925↑18% | — |
| 2017 | $226,504↑547% | $183,451↑264% | $67,737↓49% | — |
| 2016 | $35,003↓88% | $50,396↓83% | $133,064↑232% | — |
| 2015 | $294,873↑507% | $295,152↑381% | $40,076↓82% | — |
| 2014 | $48,596↓83% | $61,404↓74% | $228,438↑237% | — |
| 2013 | $288,019 | $234,855 | $67,758 | — |
Frequently Asked Questions
What does American-brazilian Aesthetic Meeting do?▼
American-brazilian Aesthetic Meeting is a diseases, disorders & medical disciplines nonprofit organization based in Utah. It is classified under NTEE code G9B and is registered as a 501(c) tax-exempt organization with the IRS.
Is American-brazilian Aesthetic Meeting financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for American-brazilian Aesthetic Meeting.
How much revenue does American-brazilian Aesthetic Meeting generate?▼
American-brazilian Aesthetic Meeting reports $393K in annual revenue and holds $464K in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Diseases, Disorders & Medical Disciplines category, or browse all nonprofits in Utah.